| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(87)91481-4 |
| P698 | PubMed publication ID | 2889967 |
| P2093 | author name string | S Moncada | |
| M W Radomski | |||
| R M Palmer | |||
| P2860 | cites work | An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation | Q28244623 |
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Human vascular smooth muscle responses mediated by alpha 2 mechanisms in vivo and in vitro | Q41339206 | ||
| Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries | Q41381379 | ||
| Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. | Q42091793 | ||
| The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide | Q42849616 | ||
| Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets | Q42849786 | ||
| Release of endothelium-derived relaxing factor from human umbilical vessels. | Q50903733 | ||
| The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. | Q52774186 | ||
| P433 | issue | 8567 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1057-1058 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium | |
| P478 | volume | 2 |
| Q43515037 | 17beta-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta |
| Q59175824 | A Fluorescence Switch for the Detection of Nitric Oxide and Histidine and Its Application in Live Cell Imaging |
| Q92493115 | A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress |
| Q88173270 | A Tailorable In-Situ Light-Activated Biodegradable Vascular Scaffold |
| Q43588772 | A comparison of the antiplatelet effect of S-nitrosoglutathione in whole blood and platelet-rich plasma |
| Q35124111 | A flow cytometric analysis of the inhibition of platelet reactivity due to nitrite reduction by deoxygenated erythrocytes. |
| Q41835276 | A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations |
| Q46050405 | A redox site involved in integrin activation |
| Q74259336 | A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function |
| Q38516928 | Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine |
| Q91594139 | Acetylcholine Inhibits Platelet Activation |
| Q72578113 | Acute normovolaemic anaemia prevents ethanol-induced gastric damage in rats through a blood flow related mechanism |
| Q47563183 | Addition of Estradiol to Cross-Sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE-/- Mice. |
| Q52520465 | Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. |
| Q36007853 | Advances in diabetes for the millennium: diabetes and the endothelium |
| Q34588824 | Advances towards understanding heart valve response to injury. |
| Q35375871 | Age-related Notch-4 quiescence is associated with altered wall remodeling during vein graft adaptation |
| Q40041537 | Angiotensin II Blockade and Total Cardiovascular Risk : Beyond Blood Pressure Reduction |
| Q43983385 | Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone |
| Q42440121 | Anti-Adhesive Effect of Nitric Oxide on Plasmodium falciparum Cytoadherence under Flow |
| Q36337932 | Anti-inflammatory effects of statins: clinical evidence and basic mechanisms |
| Q26776077 | Anticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current Rationale |
| Q36018283 | Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. |
| Q37426198 | Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of sex. |
| Q44587860 | Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272. |
| Q43597032 | Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: the effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings |
| Q33888171 | Antithrombotic and prothrombotic activities of the vascular endothelium |
| Q78095095 | Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study |
| Q37278531 | Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. |
| Q41285088 | Arginase as a mediator of diabetic retinopathy |
| Q50143099 | Arginase: A Multifaceted Enzyme Important in Health and Disease. |
| Q38452432 | Arginase: an old enzyme with new tricks |
| Q36886130 | Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females |
| Q74828390 | Aspirin inhibits granulocyte and monocyte adherence to saphenous vein endothelia in a process not mediated by nitric oxide |
| Q28168267 | Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation |
| Q37352045 | Association between arterial stiffness and variations in oestrogen-related genes. |
| Q51694318 | Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes |
| Q38299834 | Association of G894T polymorphism in endothelial nitric oxide synthase gene with the risk of ischemic stroke: A meta-analysis |
| Q60405902 | Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients |
| Q37475861 | Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis |
| Q33696610 | Association of the eNOS E298D polymorphism and the risk of myocardial infarction in the Greek population |
| Q44632874 | Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease |
| Q38691756 | Atherosclerotic cardiovascular disease: a review of initiators and protective factors. |
| Q43070990 | Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release |
| Q64229417 | Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Q53311100 | Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. |
| Q54104969 | Bacterial infection in the pathogenesis of variceal bleeding. |
| Q41963236 | Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice |
| Q33876371 | Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. |
| Q37315678 | Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis |
| Q36327570 | Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. |
| Q35084723 | Beyond lipid-lowering: effects of statins on endothelial nitric oxide |
| Q38274417 | Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein |
| Q47732809 | Biomimetic microfluidic platform for the quantification of transient endothelial monolayer permeability and therapeutic transport under mimicked cancerous conditions. |
| Q35155556 | Biosynthesis and Role of the Endothelium‐Derived Vasodilator, Nitric Oxide, in the Gastric Mucosa |
| Q38112043 | Carbon monoxide transport and actions in blood and tissues |
| Q33537331 | Cardiac bypass haemostasis: putting blood through the mill |
| Q34147762 | Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway |
| Q38409627 | Cardiac valve interstitial cells: regulator of valve structure and function |
| Q64279302 | Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury |
| Q36419650 | Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia |
| Q37342170 | Caveolin-1 scaffolding domain promotes leukocyte adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat mesenteric venules. |
| Q37591188 | Characterization of a fluorescent probe for imaging nitric oxide. |
| Q49373215 | Chlorinated Lipids Elicit Inflammatory Responses In Vitro and In Vivo. |
| Q59573861 | Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease |
| Q34153369 | Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs |
| Q34489684 | Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction. |
| Q38783337 | Comparative evaluation of the efficacy of the cyclooxygenase pathway inhibitor and nitric oxide synthase inhibitor in the reduction of alveolar bone loss in ligature induced periodontitis in rats: An experimental study |
| Q38373395 | Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate |
| Q41085913 | Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide |
| Q47821653 | Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62). |
| Q71643284 | Cyclic nucleotide regulation of interleukin-1β induced nitric oxide synthase expression in vascular smooth muscle cells |
| Q46671704 | Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes |
| Q35563263 | Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension |
| Q38281762 | Depressor action and vasorelaxation of methylene chloride fraction extracted from Rubus coreanum |
| Q48387521 | Dietary supplementation with sodium nitrite can exert neuroprotective effects on global cerebral ischemia/reperfusion in mice |
| Q77221372 | Difference in acetylcholine-induced nitric oxide release of arterial and venous grafts in patients after coronary bypass operations |
| Q68310351 | Different interactions of platelets with arterial and venous coronary bypass vessels |
| Q47671119 | Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation. |
| Q72992165 | Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis |
| Q42396289 | Direct, real-time measurement of shear stress-induced nitric oxide produced from endothelial cells in vitro. |
| Q28256613 | Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria |
| Q41852780 | Dobesilate enhances endothelial nitric oxide synthase-activity in macro- and microvascular endothelial cells |
| Q37215663 | Does carbon monoxide have a physiological function? |
| Q74045118 | Down-regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy |
| Q57175047 | Drinking Water Nitrate and Human Health: An Updated Review |
| Q38964342 | Drug Treatment of Hypertension: Focus on Vascular Health. |
| Q58754803 | Dysfunction and Therapeutic Potential of Endothelial Progenitor Cells in Diabetes Mellitus |
| Q33995596 | Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme |
| Q69369663 | EDRF and microvascular constriction after angioplasty |
| Q41836203 | Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm |
| Q34577209 | Effect of blood nitrite and nitrate levels on murine platelet function |
| Q77750533 | Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction |
| Q45051451 | Effect of nitric oxide on circular muscle of the canine small intestine |
| Q73194210 | Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients |
| Q44594430 | Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action |
| Q34510978 | Effects of antihypertensive drugs on endothelial dysfunction: clinical implications |
| Q46968117 | Effects of bioactive ceramics on the pathogenesis of rat vascular smooth muscle cells treated with phorbol 12-myristate 13-acetate |
| Q73597625 | Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension |
| Q69375610 | Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man |
| Q41721107 | Effects of inhaled nitric oxide and surfactant treatment on lung function and pulmonary hemodynamics in bronchoalveolar-lavage-induced respiratory failure |
| Q41120249 | Effects of nitric oxide on cholesterol metabolism in macrophages |
| Q74752453 | Effects of radiation on endothelial function |
| Q42524781 | Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats |
| Q40582611 | Endogenous mediators and thrombophilia |
| Q72719848 | Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver |
| Q73137299 | Endogenous nitric oxide release modulates mural platelet thrombosis and neutrophil-endothelium interactions under low and high shear conditions |
| Q36721164 | Endothelial NO synthase gene polymorphisms and risk of ischemic stroke in Asian population: a meta-analysis |
| Q33916398 | Endothelial arginine resynthesis contributes to the maintenance of vasomotor function in male diabetic mice. |
| Q38423843 | Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation |
| Q40023475 | Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha |
| Q41635553 | Endothelial dysfunction and atherothrombotic occlusive disease. |
| Q36766914 | Endothelial effects of antihypertensive treatment: focus on irbesartan |
| Q87367260 | Endothelial nitric oxide (eNOS) gene G894T and VNTR polymorphisms are closely associated with the risk of ischemic stroke development for Asians: meta-analysis of epidemiological studies |
| Q33815804 | Endothelial nitric oxide in humans in health and disease. |
| Q36937814 | Endothelial nitric oxide synthase gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head |
| Q84781225 | Endothelial nitric oxide synthase gene polymorphisms (−786T>C, 4a4b, 894G>T) and haplotypes in Korean patients with recurrent spontaneous abortion |
| Q85310796 | Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population |
| Q54606431 | Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy. |
| Q47214876 | Endothelial nitric oxide synthase gene polymorphisms in patients with slow coronary flow |
| Q54278132 | Endothelial nitric oxide synthase polymorphism G298T in association with oxidative DNA damage in coronary atherosclerosis. |
| Q42150409 | Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets |
| Q74086092 | Endothelium-dependent hyperpolarization as a remote anti-atherogenic mechanism |
| Q34578188 | Endothelium-dependent vascular responses. Mediators and mechanisms |
| Q31926360 | Endothelium-dependent vasoactive modulation in the ophthalmic circulation |
| Q70191679 | Endothelium-derived relaxing and contracting factors: perspectives in nephrology |
| Q37392083 | Endothelium-derived relaxing factor and the pulmonary circulation |
| Q42449999 | Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium |
| Q33567885 | Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells |
| Q37888810 | Endothelium-derived vasoactive factors and regulation of vascular tone in human blood vessels |
| Q57704409 | Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension |
| Q34993502 | Epidemiology and pathophysiology of peripheral arterial disease |
| Q37109255 | Erythropoietin in heart and vessels: focus on transcription and signalling pathways |
| Q35877133 | Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells |
| Q60917809 | Evaluation of Continuous Lactate Monitoring Systems within a Heparinized In Vivo Porcine Model Intravenously and Subcutaneously |
| Q71714412 | Evaluation of nitric oxide as a mediator of severe preeclampsia |
| Q36100829 | Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria. |
| Q41154240 | Factors Associated with Nitric Oxide-mediated β2 Integrin Inhibition of Neutrophils |
| Q34687823 | Fibroblast growth factors in myocardial ischemia / reperfusion injury and ischemic preconditioning |
| Q39080324 | GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease |
| Q50931838 | Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. |
| Q33771819 | Gender dimorphisms in progenitor and stem cell function in cardiovascular disease |
| Q28384335 | Gene polymorphisms in association with self-reported stroke in US adults |
| Q35652189 | Gene therapy for vascular diseases |
| Q34683905 | Genes and abdominal aortic aneurysm |
| Q87345613 | Genetic association studies of endothelial nitric oxide synthase gene polymorphisms in women with unexplained recurrent pregnancy loss: a systematic and meta-analysis |
| Q26824460 | Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction |
| Q28595571 | Globin X is a six-coordinate globin that reduces nitrite to nitric oxide in fish red blood cells |
| Q35750794 | Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols |
| Q42468512 | Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression |
| Q36218323 | HbS Binding to GP1bα Activates Platelets in Sickle Cell Disease |
| Q37038730 | Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome |
| Q36466804 | Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide |
| Q36337571 | Hemoglobin interaction with GP1bα induces platelet activation and apoptosis: a novel mechanism associated with intravascular hemolysis. |
| Q41043530 | Hemoglobin-nitric oxide interaction and its implications |
| Q36051140 | Hemolysis-Associated Nitric Oxide Dysregulation during Extracorporeal Membrane Oxygenation. |
| Q42575662 | Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! |
| Q38693107 | Heparin-binding EGF-like growth factor promotes neuronal nitric oxide synthase expression and protects the enteric nervous system after necrotizing enterocolitis |
| Q59403027 | High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis |
| Q33596730 | High-density lipoprotein: multipotent effects on cells of the vasculature. |
| Q34514079 | Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase. |
| Q35185593 | Historical perspective and future directions in platelet research |
| Q34298013 | Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor |
| Q74572065 | Hyperammonemia reduces water immersion--restraint stress gastric ulcers in rats |
| Q42604563 | Hypercoagulability and thrombotic complications in hemolytic anemias. |
| Q61648643 | Hypoxia Increases Vasodilator Release From Internal Mammary Artery and Saphenous Vein Grafts |
| Q37730288 | Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide |
| Q42435256 | Impaired NO release from bovine aortic endothelial cells exposed to activated platelets |
| Q41715228 | Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease |
| Q50528272 | Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract--role of free radicals and attenuation by captopril. |
| Q31146533 | Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions |
| Q39096236 | In Vivo Chemical Sensors: Role of Biocompatibility on Performance and Utility. |
| Q48022785 | In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants |
| Q34188808 | In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. |
| Q42944020 | Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. |
| Q51554134 | Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism. |
| Q42467633 | Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease |
| Q37088422 | Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice |
| Q34730450 | Increased superoxide generation and decreased stress protein Hsp90 expression in human umbilical cord vein endothelial cells (HUVECs) from pregnancies complicated by preeclampsia |
| Q36877791 | Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition |
| Q24795387 | Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress |
| Q35782707 | Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. |
| Q24564394 | Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation |
| Q33947042 | Inducible nitric oxide synthase: a little bit of good in all of us |
| Q41214629 | Induction of cyclo-oxygenase and nitric oxide synthase in inflammation |
| Q95303662 | Induction of selective liver hypothermia prevents significant ischemia/reperfusion injury in Wistar rats after 24 hours |
| Q37003565 | Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration? |
| Q42103330 | Influence of basal nitric oxide secretion on cardiac function in man. |
| Q71379675 | Inhaled nitric oxide improves lung allograft function after prolonged storage |
| Q41628605 | Inhaled nitric oxide in the premature infant: animal models and clinical experience |
| Q41022241 | Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes |
| Q35997112 | Inhibition of Hb Binding to GP1bα Abrogates Hb-Mediated Thrombus Formation on Immobilized VWF and Collagen under Physiological Shear Stress |
| Q35042989 | Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy |
| Q43141419 | Inhibition of inducible nitric oxide synthase worsens liver damage regardless of lipopolysaccharide treatment in small-for-size liver transplantation |
| Q41140097 | Inhibition of nitric oxide synthase by antisense techniques: investigations of the roles of NO produced by murine macrophages |
| Q46145584 | Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat |
| Q71657934 | Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty |
| Q42798216 | Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). |
| Q41950416 | Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine |
| Q34171219 | Inhibitors of nitric oxide promote microvascular thrombosis |
| Q41874552 | Inhibitory Effect of Ginsenoside Rg1 on Vascular Smooth Muscle Cell Proliferation Induced by PDGF-BB Is Involved in Nitric Oxide Formation |
| Q35552149 | Inorganic nitrite therapy: historical perspective and future directions. |
| Q37142734 | Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS. |
| Q34150577 | Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes |
| Q35214644 | Insulin resistance and endothelial dysfunction |
| Q44396503 | Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences. |
| Q42371085 | Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia |
| Q44555273 | Involvement of the proteasome in activation of endothelial nitric oxide synthase |
| Q40440914 | Is endothelial dysfunction reversible? |
| Q83751237 | Is endothelial-nitric-oxide-synthase-derived nitric oxide involved in cardiac hypoxia/reoxygenation-related damage? |
| Q73244244 | Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction |
| Q36496428 | Japanese herbal medicine, Saiko-keishi-to, prevents gut ischemia/reperfusion-induced liver injury in rats via nitric oxide. |
| Q21284797 | Lipoprotein(a) in cardiovascular diseases |
| Q30476296 | Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics |
| Q74284515 | Liver dysfunction elicited by gut ischemia-reperfusion |
| Q73983912 | Long-term cold ischemia reduces nitric oxide metabolism in reperfused rabbit kidneys |
| Q44315171 | Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure |
| Q36421859 | Long-term effect of PROLI/NO on cellular proliferation and phenotype after arterial injury. |
| Q47639600 | Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers. |
| Q44452301 | Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure |
| Q51564071 | Maternal serum nitric oxide levels associated with biochemical and clinical parameters in hypertension in pregnancy. |
| Q28218042 | Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets |
| Q40602825 | Mechanisms of action of nitrates |
| Q40486896 | Mechanisms of restenosis |
| Q36868851 | Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. |
| Q48595239 | Microcirculation and red cell transfusion in patients with sepsis. |
| Q35026501 | Microcirculation as a target for the anti-inflammatory properties of statins. |
| Q35127246 | Minireview: Adiposity, Inflammation, and Atherogenesis |
| Q99406425 | Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study |
| Q42920786 | Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. |
| Q73006761 | Modulation of P-selectin expression on isolated human platelets by an NO donor assessed by a novel ELISA application |
| Q40498058 | Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion |
| Q34085037 | Molecular mechanisms of estrogen actions on the vasculature |
| Q74106093 | Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells |
| Q43189343 | N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries |
| Q77420297 | N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery |
| Q33625854 | NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein |
| Q33269570 | NG-monomethyl-l-arginine increases platelet deposition on damaged endothelium in vivo. A scanning electron microscopic study |
| Q90184613 | Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion under Physiologic Conditions |
| Q57821326 | Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress |
| Q40988769 | Neural and endothelial control of the peripheral circulation--implications for anesthesia: Part II, Endothelium-mediated effects in the normal and diseased circulation |
| Q74075583 | Neutrophils, lipid peroxidation, and nitric oxide in gastric reperfusion injury in rats |
| Q42054472 | New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes |
| Q41711755 | New antiplatelet drugs |
| Q64121712 | Nitric Oxide Reverses the Position of the Heart during Embryonic Development |
| Q70928358 | Nitric oxide |
| Q33701403 | Nitric oxide and arginine |
| Q34019768 | Nitric oxide and intestinal inflammation |
| Q40418256 | Nitric oxide and its role in the cardiovascular system |
| Q36497132 | Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia |
| Q41628597 | Nitric oxide and platelet function: implications for neonatology |
| Q46332401 | Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults |
| Q37733072 | Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention |
| Q34027835 | Nitric oxide and the gut. |
| Q33907931 | Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke |
| Q57689686 | Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke |
| Q24245090 | Nitric oxide for preventing pre-eclampsia and its complications |
| Q41589345 | Nitric oxide generation by nitric oxide synthase isoforms in transplanted vessels |
| Q42451736 | Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus |
| Q36814343 | Nitric oxide homeostasis as a target for drug additives to cardioplegia |
| Q33340603 | Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. |
| Q42009952 | Nitric oxide in the human cardiovascular system--SKB lecture 1997. |
| Q40390542 | Nitric oxide in the kidney: synthesis, localization, and function |
| Q41642253 | Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects |
| Q48291448 | Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion |
| Q54066698 | Nitric oxide metabolism in canine sepsis: relation to regional blood flow. |
| Q41914476 | Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart |
| Q30410620 | Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes |
| Q64380995 | Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells |
| Q41170862 | Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules |
| Q36816237 | Nitric oxide regulation of protein trafficking in the cardiovascular system |
| Q46503606 | Nitric oxide release from polydimethylsiloxane-based polyurethanes. |
| Q50514156 | Nitric oxide synthase inhibitor attenuates inflammatory lesions in the skin of zinc-deficient rats. |
| Q33594387 | Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress |
| Q34934327 | Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease |
| Q35090361 | Nitric oxide, platelet function, myocardial infarction and reperfusion therapies |
| Q30475217 | Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia |
| Q34725803 | Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin |
| Q40399921 | Nitric oxide. Novel biology with clinical relevance |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q37519420 | Nitric oxide: an endogenous modulator of leukocyte adhesion |
| Q41005261 | Nitric oxide: delivery, measurement, and clinical application |
| Q44582063 | Normalization by edaravone, a free radical scavenger, of irradiation-reduced endothelial nitric oxide synthase expression |
| Q36558565 | Nutrigenomics: a case for the common soil between cardiovascular disease and cancer |
| Q43087406 | On the protective mechanisms of nitric oxide in acute pancreatitis |
| Q38696169 | Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system. |
| Q33693578 | Outgrowing endothelial and smooth muscle cells for tissue engineering approaches |
| Q37774078 | Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy |
| Q38552623 | Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation |
| Q34963325 | Peroxynitrite in myocardial ischemia-reperfusion injury |
| Q37299480 | Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy |
| Q28190911 | Pharmacological characteristics of solid-phase von Willebrand factor in human platelets |
| Q40597413 | Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry |
| Q33558813 | Pharmacology of endothelium-derived nitric oxide and nitrovasodilators |
| Q43164496 | Physiological importance of nitric oxide |
| Q37042201 | Plasma ADMA predicts restenosis of arteriovenous fistula. |
| Q35674171 | Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty |
| Q43186392 | Platelet activation in essential hypertension: implications for antiplatelet treatment |
| Q44374170 | Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro |
| Q33569525 | Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase |
| Q51526914 | Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. |
| Q44885635 | Platelet cGMP inversely correlates with age in healthy subjects |
| Q60728360 | Platelet deposition after angioplasty is abolished by restoration of the endothelial cell monolayer |
| Q64123690 | Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001 |
| Q37175605 | Platelet receptors and signaling in the dynamics of thrombus formation. |
| Q35872034 | Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro |
| Q40430459 | Platelets and Platelet Inhibitors in Acute Myocardial Infarction |
| Q36334304 | Platelet—neutrophil interactions: Their significance |
| Q34189108 | Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. |
| Q37137106 | Potential Benefits of Peroxynitrite |
| Q35026662 | Potential renovascular hypertension, space missions, and the role of magnesium |
| Q73271039 | Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity |
| Q37969678 | Primary pulmonary hypertension: diagnosis, medical and surgical treatment |
| Q43179555 | Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug |
| Q28319715 | Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man |
| Q72786754 | Protection against gastric ischemia-reperfusion injury by nitric oxide generators |
| Q34480327 | Protective role of nitric oxide in ischemia and reperfusion injury of the liver |
| Q41719637 | Pulmonary blood flow alters nitric oxide production in patients undergoing device closure of atrial septal defects |
| Q35415178 | Purinergic receptors, prostacyclin and atherosclerosis |
| Q34964032 | Rapid vascular cell responses to estrogen and membrane receptors |
| Q34455919 | Reactive oxygen intermediates involved in cellular regulation |
| Q36574160 | Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria |
| Q40541975 | Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn |
| Q47648249 | Reduction of Endothelial Nitric Oxide Increases the Adhesiveness of Constitutive Endothelial Membrane ICAM-1 through Src-Mediated Phosphorylation |
| Q37191440 | Reductive gas-phase chemiluminescence and flow injection analysis for measurement of the nitric oxide pool in biological matrices |
| Q34356067 | Refinement, reduction and replacement approaches to in vivo cardiovascular research |
| Q34566845 | Regulation of L-arginine transport and metabolism in vascular smooth muscle cells |
| Q35721799 | Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. |
| Q33928520 | Regulation of platelet granule exocytosis by S-nitrosylation |
| Q40945736 | Regulation of the expression of the inducible isoform of nitric oxide synthase |
| Q33740877 | Relationship between monocyte-platelet aggregation and endothelial function in middle-aged and elderly adults |
| Q34243673 | Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide |
| Q30489561 | Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials |
| Q34424737 | Rg3-enriched Korean Red Ginseng improves vascular function in spontaneously hypertensive rats. |
| Q40968273 | Role of Nitric Oxide in Hemostatic System Activation In Vivo in Humans |
| Q42094036 | Role of extracellular hemoglobin in thrombosis and vascular occlusion in patients with sickle cell anemia |
| Q73846777 | Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities |
| Q41837736 | Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. |
| Q74558115 | Role of nitric oxide in oxidative damage in isolated rabbit gastric cells exposed to hypoxia-reoxygenation |
| Q31447903 | Role of nitric oxide in the control of burn perfusion |
| Q71093811 | Role of nitric oxide in the effect of blood flow on neointima formation |
| Q88947995 | Role of the circadian system in cardiovascular disease |
| Q37700095 | Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics |
| Q34571118 | S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia |
| Q72511882 | S-nitroso-N-acetylpenicillamine reduces leukocyte adhesion to type I collagen |
| Q35368647 | S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo |
| Q41882015 | S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery |
| Q73962494 | Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1 |
| Q37664560 | Serum nitric oxide levels in patients with coronary artery ectasia. |
| Q42125074 | Shear stress-induced NO production is dependent on ATP autocrine signaling and capacitative calcium entry. |
| Q33397541 | Shiga toxin pathogenesis: kidney complications and renal failure |
| Q54162157 | Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury. |
| Q36231518 | Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin |
| Q54090679 | Superior protection in orthotopic rat lung transplantation with cyclic adenosine monophosphate and nitroglycerin-containing preservation solution. |
| Q41971623 | Superoxide anions enhance platelet adhesion and aggregation |
| Q58762428 | Synthesis and Characterization of Controlled Nitric Oxide Release from -Nitroso--Acetyl-d-Penicillamine Covalently Linked to Polyvinyl Chloride (SNAP-PVC) |
| Q36661502 | Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury |
| Q96018023 | Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost |
| Q34648936 | Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration |
| Q33392407 | The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus |
| Q44808681 | The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers |
| Q44146848 | The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis |
| Q71799276 | The Interstitium of the Human Arterial Wall Contains Very Large Amounts of Extracellular Superoxide Dismutase |
| Q77386478 | The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile |
| Q36683193 | The anti-inflammatory and analgesic action of transdermal glyceryltrinitrate in the treatment of infusion-related thrombophlebitis |
| Q90859261 | The association between metabolic syndrome components and the development of atherosclerosis |
| Q35992138 | The cardioprotective power of leaves |
| Q90029373 | The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon |
| Q33422287 | The clinical implications of thrombocytopenia in adults with severe falciparum malaria: a retrospective analysis |
| Q37283920 | The eNOS 894G/T gene polymorphism and its influence on early and long-term mortality after on-pump cardiac surgery |
| Q68065246 | The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man |
| Q42448372 | The effect of hypercholesterolemia on platelet soluble guanylyl cyclase |
| Q70493623 | The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro |
| Q36834910 | The endothelial L-arginine/nitric oxide pathway and the renal circulation |
| Q57429952 | The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case–control studies |
| Q74126272 | The mechanism of nitric oxide and/or superoxide cytotoxicity in endothelial cells |
| Q34809204 | The nitration of proteins in platelets: significance in platelet function |
| Q67786093 | The nitric oxide donor SIN-1 is a potent inhibitor of plasminogen activator inhibitor release from stimulated platelets |
| Q73037003 | The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation |
| Q34532281 | The nitric oxide-endothelin-1 connection |
| Q35959298 | The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation |
| Q35870524 | The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit |
| Q38156780 | The platelet fibrinogen receptor: from megakaryocyte to the mortuary |
| Q95805497 | The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells |
| Q77291990 | The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces |
| Q41296205 | The prostacyclin stimulating plasma factor activity improves thromboresistance only if vascular PGI2-production is intact |
| Q33599393 | The relation between hypoalbuminemia and compliance and intima-media thickness of carotid artery in continuous ambulatory peritoneal dialysis patients |
| Q40906546 | The relationship between erectile dysfunction and paroxysmal lone atrial fibrillation. |
| Q39342123 | The role of inorganic nitrate and nitrite in CVD. |
| Q41852095 | The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit |
| Q26801407 | The role of platelets in the recruitment of leukocytes during vascular disease |
| Q34064170 | The role of protein kinase C in the development of the complications of diabetes |
| Q81449866 | The theoretical comparison between two model NO carriers, MeSNO and MeSeNO |
| Q41858633 | The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors |
| Q36053698 | The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension |
| Q30490373 | Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke |
| Q36973472 | Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction |
| Q31886177 | Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases |
| Q33397103 | Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis |
| Q30411302 | Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice. |
| Q37265733 | Uric acid and insulin sensitivity and risk of incident hypertension |
| Q37030271 | Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease |
| Q36620184 | Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway |
| Q36329845 | Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. |
| Q33501391 | Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium |
| Q44794739 | Young male smokers have altered platelets and endothelium that precedes atherosclerosis. |
| Q79711880 | [Infection and variceal bleeding in cirrhosis] |
| Q73448323 | [Roles of vasoactive factors synthetized by endothelium in pulmonary arterial hypertension] |
| Q74564766 | [The role of endothelial function for ischemic manifestations of coronary atherosclerosis] |
| Q24305875 | beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90 |
| Q61718048 | l-Arginine Modulates Aggregation and Intracellular Cyclic 3′,5′-Guanosine Monophosphate Levels in Human Platelets |
| Q46045930 | l-Arginine supplementation protects against hepatic ischemia-reperfusion lesions in rabbits |
| Q34310327 | l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats. |
Search more.